81 related articles for article (PubMed ID: 16412569)
1. mtDNA mutations in invasive cervix tumors: a retrospective analysis.
Allalunis-Turner J; Ma I; Hanson J; Pearcey RG
Cancer Lett; 2006 Nov; 243(2):193-201. PubMed ID: 16412569
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer.
Tseng LM; Yin PH; Chi CW; Hsu CY; Wu CW; Lee LM; Wei YH; Lee HC
Genes Chromosomes Cancer; 2006 Jul; 45(7):629-38. PubMed ID: 16568452
[TBL] [Abstract][Full Text] [Related]
3. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
4. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients.
Yu M; Zhou Y; Shi Y; Ning L; Yang Y; Wei X; Zhang N; Hao X; Niu R
IUBMB Life; 2007 Jul; 59(7):450-7. PubMed ID: 17654121
[TBL] [Abstract][Full Text] [Related]
5. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Gasparre G; Hervouet E; de Laplanche E; Demont J; Pennisi LF; Colombel M; Mège-Lechevallier F; Scoazec JY; Bonora E; Smeets R; Smeitink J; Lazar V; Lespinasse J; Giraud S; Godinot C; Romeo G; Simonnet H
Hum Mol Genet; 2008 Apr; 17(7):986-95. PubMed ID: 18156159
[TBL] [Abstract][Full Text] [Related]
7. Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.
Cui B; Zheng B; Zhang X; Stendahl U; Andersson S; Wallin KL
Int J Oncol; 2009 Feb; 34(2):409-16. PubMed ID: 19148475
[TBL] [Abstract][Full Text] [Related]
8. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome.
Navaglia F; Basso D; Fogar P; Sperti C; Greco E; Zambon CF; Stranges A; Falda A; Pizzi S; Parenti A; Pedrazzoli S; Plebani M
Am J Clin Pathol; 2006 Oct; 126(4):593-601. PubMed ID: 16938655
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
11. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
Chetrit A; Hirsh-Yechezkel G; Ben-David Y; Lubin F; Friedman E; Sadetzki S
J Clin Oncol; 2008 Jan; 26(1):20-5. PubMed ID: 18165636
[TBL] [Abstract][Full Text] [Related]
12. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Mayr JA; Meierhofer D; Zimmermann F; Feichtinger R; Kögler C; Ratschek M; Schmeller N; Sperl W; Kofler B
Clin Cancer Res; 2008 Apr; 14(8):2270-5. PubMed ID: 18413815
[TBL] [Abstract][Full Text] [Related]
13. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.
Semczuk A; Lorenc A; Putowski L; Futyma K; Bryk J; Miotla P; Bartnik E
Oncol Rep; 2006 Nov; 16(5):1041-5. PubMed ID: 17016590
[TBL] [Abstract][Full Text] [Related]
14. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
Ma SK; Wu LY; Sun YC; Li B; Zhang HT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
16. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
Torbé B
Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
[TBL] [Abstract][Full Text] [Related]
17. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients.
Wong LJ; Lueth M; Li XN; Lau CC; Vogel H
Cancer Res; 2003 Jul; 63(14):3866-71. PubMed ID: 12873974
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India.
Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Ghoshal S; Kumar V; Kapoor R
Radiother Oncol; 2006 May; 79(2):142-6. PubMed ID: 16677730
[TBL] [Abstract][Full Text] [Related]
19. Clonal expansion of different mtDNA variants without selective advantage in solid tumors.
Gekeler J; Zsurka G; Kunz WS; Preuss SF; Klussmann JP; Guntinas-Lichius O; Wiesner RJ
Mutat Res; 2009 Mar; 662(1-2):28-32. PubMed ID: 19114048
[TBL] [Abstract][Full Text] [Related]
20. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients].
Li HX; Zhong S; Li CH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):290-3. PubMed ID: 12895314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
